Haijun Gu

发表

Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer.

Yuan He, Z. Yi, Yihua Chen, 2022, Future medicinal chemistry.

A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression

Mingyao Liu, Yuan He, Z. Yi, 2021, Clinical and translational medicine.

Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of N-phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth.

Mingyao Liu, Xiufeng Pang, Z. Yi, 2020, Journal of medicinal chemistry.

B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas.

Yihua Chen, Weikai Guo, Bo Liu, 2022, Journal of medicinal chemistry.

Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment.

Mingyao Liu, Z. Yi, Yihua Chen, 2022, Journal of medicinal chemistry.

Syringin protects against colitis by ameliorating inflammation.

Qiumei Shi, Haihua Zhang, Xin Liu, 2019, Archives of biochemistry and biophysics.

Current advances of small molecule E3 ligands for proteolysis-targeting chimeras design.

Yuzhan Li, Yan Li, Dazhao Mi, 2023, European journal of medicinal chemistry.

An Emerging Therapeutic Approach by Targeting Myoferlin (MYOF) for Malignant Tumors.

Yihua Chen, Yangrui Peng, Haijun Gu, 2020, Current topics in medicinal chemistry.

Novel orthodiphenyl five-member N-heteroaromatic compounds as potent anticancer cell agents

Z. Yi, Yihua Chen, Shijia Hu, 2022, Medicinal Chemistry Research.